RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Operating income

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.9B
P/E ratio
SummaryFinancials
Period EndOperating income (Million USD)YoY (%)
Dec 31, 2024-475+34.31%
Dec 31, 2023-354-13.76%
Dec 31, 2022-410+1258.88%
Dec 31, 2021-30-82.46%
Dec 31, 2020-172-147.03%
Dec 31, 2019366-696.17%
Dec 31, 2018-61-350.15%
Dec 31, 201725-152.97%
Dec 31, 2016-46-38.87%
Dec 31, 2015-76+58.73%
Dec 31, 2014-48-7.62%
Dec 31, 2013-52-25.04%
Dec 31, 2012-69-3.06%
Dec 31, 2011-71+47.03%
Dec 31, 2010-48

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)